Clinical Cancer Research

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Clinical Cancer Research
Dec 19, 2024, 02:26 | Science
Nicholas Hornstein: CtDNA for Appendiceal Adenocarcinoma is not as robust as in Colorectal Cancer
Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X…
Nov 14, 2024, 09:09 | Blog
Winette van der Graaf: Highlighting the partnership with National Cancer Grid India
Winette van der Graaf, Head of Department of Medical Oncology at Netherlands Cancer Institute, made the…
Oct 27, 2024, 16:57 | Blog
Harold J. Burstein: 71% of US counties either lack an oncologist or lack an open cancer trials
Harold J. Burstein, Breast cancer specialist and Professor, Harvard Medical School, shared a post on…
Oct 23, 2024, 10:00 | Insight
MD Anderson Research Highlights
Featuring novel targets for breast cancer, epigenetic strategies to improve immune responses, a treatment for…
Oct 23, 2024, 00:08 | Insight
Maryam Yazdy: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-cell Lymphomas
Maryam Yazdy, Senior Physician on the Lymphoma team in the Division of Hematologic Malignancies 2…
Oct 18, 2024, 15:37 | Insight
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
On October 18, 2024, during the Global Summit and Award Ceremonies for Cancer Research and…
Oct 3, 2024, 17:50 | Insight
Maria Babak: Vimseltinib in treating TGCT is definitely one to watch
Maria Babak shared a post on LinkedIn by The Babak Lab, about a recent paper…
Sep 25, 2024, 13:30 | Blog
Matteo Dugo: Neoadjuvant atezolizumab plus chemotherapy in TNBC
Matteo Dugo shared a post on LinkedIn, about recent paper published in Clinical Cancer Research:…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 21, 2024, 14:32 | Insight
Alex Wyatt: Will ctDNA serve as a treatment response biomarker in metastatic cancers
Alex Wyatt, Associate Professor at Vancouver Prostate Centre, shared a post on X about a…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 9, 2024, 14:35 | Blog
A three-year $200,000 grant for cancer research - Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation shared the following on LinkedIn: “Cancer research takes dedication and…
Aug 29, 2024, 02:52 | Insight
Analysis of cfDNA Reveals Stemness Linked to Poor Survival in Lethal Prostate Cancer
Pradeep Chauhan, Radiation Oncologist at Mayo Clinic, shared a post about his latest paper on…
Aug 28, 2024, 11:11 | Blog
MD Anderson Research Highlights
Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a…
Aug 18, 2024, 06:12 | Blog
Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC
Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…
Aug 17, 2024, 08:07 | Insight
Liang Cheng: An exciting time to study bladder cancer
Liang Cheng shared on LinkedIn: "I am very happy to know that our collaborative research…
Aug 16, 2024, 19:45 | Insight
Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma
Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…
Aug 10, 2024, 14:33 | Insight
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…
Aug 10, 2024, 11:52 | Insight
Ahmad Ozair: Work from Adult Brain Tumor Consortium
Ahmad Ozair, Postdoctoral Research Fellow in Neurosurgery at  University of Maryland, shared a post on…
Aug 8, 2024, 19:43 | Insight
Alejandro Bertolet: Radiation-induced brain necrosis in proton therapy
Alejandro Bertolet, Assistant Professor of Radiation Oncology at Mass General Cancer Center, shared a post…
Aug 7, 2024, 14:42 | Insight
Ibrahim Chamseddine: Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis
Ibrahim Chamseddine, Instructor in Radiation Oncology at Harvard Medical School, shared on X: "Excited to…
Jul 31, 2024, 17:01 | Insight
Sequential Sacituzumab and Talazoparib for triple-negative breast cancer
Clinical Cancer Research shared a post on X about a recent paper by Aditya Bardia…
Jul 30, 2024, 13:23 | Insight
Treatment of CML in pregnant patients and patients who are breastfeeding
FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…
Jul 25, 2024, 08:28 | Blog
Recommendations to improve using Overall Survival data to inform benefit-risk assessments - FDA Oncology
FDA Oncology posted on X about recent paper by Lisa Rodriguez et al., commenting:  "In…
Jul 25, 2024, 06:32 | Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 25, 2024, 00:46 | Blog
FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories
AACR posted on X/Twitter about recent paper by Timil Patel et al., commenting: "A Clinical Cancer…
Jul 25, 2024, 00:17 | Blog
How to improve collection and analysis of Overall Survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared on LinkedIn: "A recent perspective paper in Clinical…
Jul 24, 2024, 07:43 | Blog
Considerations to improve collection and analysis of overall survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared a post on LinkedIn: ''A new perspective paper…
Jul 18, 2024, 22:39 | Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 14, 2024, 06:26 | Insight
Daniele Marinelli: NRF2-driven transcription in NSCLC
Daniele Marinelli, PhD student at the Sapienza University of Rome, shared a post on X…
Jul 13, 2024, 11:33 | Blog
Desert Horse-Grant: New K12 scholars of Sylvester Comprehensive Cancer Center
Desert Horse-Grant, Chief Transformation Officer at the Sylvester Comprehensive Cancer Center, shared a post on…
Jul 6, 2024, 15:02 | Blog
FDA-AACR Oncology Educational Fellowship's impact on participants
American Association for Cancer Research shared a post on LinkedIn: “An article in Clinical Cancer…
Jul 1, 2024, 12:51 | Blog
Career Development Beyond the FDA-AACR Oncology Educational Fellowship
FDA Oncology posted on X: "Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship…
Jun 28, 2024, 12:15 | Insight
Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling
Talal El Zarif, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:   .…
May 30, 2024, 02:01 | Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 26, 2024, 15:35 | Insight
Sumanta Pal: A massive effort to characterize the activity of Debio1347 by Petros Grivas and colleagues
Petros Grivas shared a post by Sumanta Pal on X/Twitter: "Thanks Sumanta Pal for highlighting our work with…
May 14, 2024, 15:36 | Insight
Andy Hahn: Congrats to Ana Aparicio and team on this trial of 192 men with mCRPC
Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Congratulations to…
May 8, 2024, 07:02 | Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 3, 2024, 05:31 | Blog
Francesco Maura: New papers on early intervention in smoldering myeloma
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center shared a thread on X: “New paper…
Apr 27, 2024, 07:10 | Insight,Opinion
Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research
Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared…
Apr 16, 2024, 01:52 | Insight,Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 12, 2024, 07:30 | Blog
Urvi Shah: Grateful that our paper was selected for the inaugural Clinical Cancer Research early career award
Urvi Shah, Hematologist-oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X: "Thank…
Dec 23, 2023, 04:00 | Insight
Vivek Subbiah: Such a delight to share our non-human primate publication as a pre-cursor to our First-in-human phase 1 trial
Vivek Subbiah shared on X/Twitter: ''Such a delight to share our non-human primate publication on First-in-cynomolgus…
Dec 9, 2023, 17:16 | Insight
Vivek Subbiah: Finding the genomic fusion needles in the haystacks via Liquid Biopsy Precision Medicine
Vivek Subbiah, shared a post by Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine and New…
Nov 25, 2023, 10:48 | Blog
Nominations for the inaugural Clinical Cancer Research Early Career Award are now open - AACR Journals
AACR Journals shared a post on LinkedIn: "Nominations for the inaugural Clinical Cancer Research Early…
Oct 14, 2023, 21:53 | Opinion
Biljana Naumovic: Building equitable access should be an all-encompassing priority – not an afterthought or a last step.
Biljana Naumovic, Worldwide Vice President Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson…
Jun 26, 2023, 19:45 | Stories
NCRI is winding down after 22 remarkable years
In a post by NCRI Partnership on Twitter, it says, "Important news: NCRI is winding…
Jun 24, 2023, 18:25 | Drugs
Still no role for targeting PI3K pathway in mCRPC - Arun Azad
Now online Clinical Cancer Research- Phase IB study ipatasertib plus ipatasertib in mCR prostate cancer…
May 28, 2023, 18:49 | Societies
The EORTC 2022 Annual Report is out!
This comprehensive report collects the most relevant and up-to-date information on EORTC's activities, demonstrating the…
All: 49 Posts: 1 - 100
Special Coverage